Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Cadence and Intensity Across the Adult Lifespan
Authors not listed
University of Massachusetts, Amherst · 2015
Abstract
The purpose of this study is to determine and link cadence (the number of steps taken in a minute) to the intensity of physical activity (e.g. low-, moderate- and vigorous-intensity) in adults (21-85 years old). The investigators anticipate that cadence will be a good indicator of exercise intensity. Identifying how cadence relates to activity intensity will allow for physical activity guidelines to be communicated to the public in a manner that is more accessible to the lay person.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2015). Cadence and Intensity Across the Adult Lifespan. <em>University of Massachusetts, Amherst</em>. https://clinicaltrials.gov/study/NCT02650258
Vancouver
Anonymous. Cadence and Intensity Across the Adult Lifespan. University of Massachusetts, Amherst. 2015.
BibTeX
@misc{anon2015Cadenc,
title = {Cadence and Intensity Across the Adult Lifespan},
author = {Anonymous},
journal = {University of Massachusetts, Amherst},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Institute on Aging (NIA) 2003
Open access · US-GOV
Combining Exercise and Diet in Older Adults
University of Florida 2016
Open access · US-GOV
Resveratrol and Exercise to Treat Functional Limitations in Late Life
Norwegian University of Science and Technology 2012
Open access · US-GOV
Self Reported Physical Activity vs Objectively Measured Physical Activity and Its Correlation to Maximal Oxygen Uptake in an Elderly Population: an Observational Study
Jiangsu Province Centers for Disease Control and Prevention 2020
Open access · US-GOV
Safety, Tolerability and Immunogenicity of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) in Chinese Healthy Population Aged 18 Years and Older: A Phase I, Single-center, Randomized, Placebo-controlled, Double-blind Study
Jiangsu Province Centers for Disease Control and Prevention 2020
Open access · US-GOV
Safety and Immunogenicity of a Recombinant COVID-19 Vaccine (CHO Cell) in Healthy Population Aged 18 Years and Older: A Phase I Study
College of St. Scholastica, Inc. 2023
Open access · US-GOV